I think the drug development route has the most innovation in the different types of compounds being created. For example, Psilera is working on a compound that removes the hallucination effect, BioMind is working with 5-MeO-DMT for depression & anxiety in Alzheimer’s. Everything from fibromyalgia to spinal industries, cluster headaches, to treatment resistant depression are being studied right now, so it’s exciting to see these medicines being used for conditions that our traditional healthcare and pharmaceutical companies haven’t been able to properly help.